Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Induced Cardiotoxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05950399
What this trial is testing

Stress Echocardiography to Identify Chemotherapy Induced Cardiotoxicity in Cancer Patients With Heart Failure Risk

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Mayo Clinic 52
Not applicableUnknownNCT04632407
What this trial is testing

Can Flaxseed Prevent Broken Hearts in Women With Breast Cancer Study?

Who this might be right for
Cardiotoxicity
St. Boniface Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT02677714
What this trial is testing

99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer

Who this might be right for
Breast CancerDoxorubicin Induced Cardiomyopathy
Advanced Accelerator Applications 14
Large-scale testing (Phase 3)Study completedNCT01230983
What this trial is testing

Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma

Who this might be right for
Cardiac ToxicityLeukemiaLymphoma
Children's Oncology Group 573
Not applicableLooking for participantsNCT07191730
What this trial is testing

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

Who this might be right for
CardiotoxicityHeart FailureNeoplasms+1 more
University Hospital, Caen 600
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Not applicableLooking for participantsNCT06282796
What this trial is testing

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
First Hospital of China Medical University 600
Not applicableStudy completedNCT01719562
What this trial is testing

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Who this might be right for
Cardiac ToxicityMalignant NeoplasmBreast Cancer
Wake Forest University Health Sciences 28
Post-approval studies (Phase 4)UnknownNCT04939883
What this trial is testing

Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy

Who this might be right for
Cancer
Hospital Sirio-Libanes 1,018
Early research (Phase 1)Study completedNCT02006979
What this trial is testing

Acute Exercise Cardioprotection From Doxorubicin

Who this might be right for
Breast Cancer
University of British Columbia 27
Not applicableNot Yet RecruitingNCT07419711
What this trial is testing

Grape Polyphenols for Prevention of Chemotherapy-Induced Cardiotoxicity

Who this might be right for
Chemotherapy-induced CardiotoxicityBreast Cancer
Nazarbayev University 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07572175
What this trial is testing

Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity

Who this might be right for
Anthracycline-induced CardiotoxicityLymphomaChemotherapy+1 more
Icahn School of Medicine at Mount Sinai 60
Large-scale testing (Phase 3)UnknownNCT02236806
What this trial is testing

Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab

Who this might be right for
Breast CancerCardiotoxicity
Azienda Ospedaliero-Universitaria Careggi 262
Not applicableStudy completedNCT01904331
What this trial is testing

Breast Cancer Long-term Outcome of Cardiac Dysfunction

Who this might be right for
Breast Neoplasms
University Medical Center Groningen 700
Not applicableUnknownNCT04047901
What this trial is testing

Effect of Physical Training in Patients With Heart Failure Caused by Chemotherapy for Cancer Treatment

Who this might be right for
Insufficiency;CardiacCancerCardiotoxicity+1 more
University of Sao Paulo General Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00019864
What this trial is testing

Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma

Who this might be right for
Cardiac ToxicitySarcoma
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Ended earlyNCT01120171
What this trial is testing

Myocet Plus Endoxan for Older Patients With Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 64
Not applicableEnded earlyNCT03850171
What this trial is testing

Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study

Who this might be right for
Breast Neoplasm FemaleLymphomaCardiotoxicity+2 more
Insel Gruppe AG, University Hospital Bern 57
Not applicableLooking for participantsNCT06622954
What this trial is testing

Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients

Who this might be right for
CardiotoxicityBreast Cancer
Erasmus Medical Center 32
Testing effectiveness (Phase 2)Ended earlyNCT01301040
What this trial is testing

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Who this might be right for
Breast Cancer
Jules Bordet Institute 2
Next Page